WASHINGTON -- Up to three scans using 18 F-fluorodeoxyglucose-enhanced positron emission tomography (FDG-PET) technology can be covered by Medicare for oncology treatment planning, the Centers for ...

The scan, FDG-PET, helped six doctors from three national Alzheimer's disease centers correctly diagnose frontotemporal dementia and Alzheimer's in almost 90 percent of cases. A PET scan (positron ...

PET scans may serve as both a diagnostic and prognostic tool in giant cell arteritis (GCA), according to a new study. In over 100 patients with GCA who underwent 18 F-fluorodeoxyglucose (FDG ...

FDG-PET imaging is not routinely employed in this type of cancer and its role in endometrial cancer is still being studied and yet to be defined. In a series of 41 whole-body PET studies conducted ...

Researchers have now shown that 18F-FDG PET scans are better than CT scans at ... and Marcella Johnson, MS from the Department of Biostatistics; all from the M.D. Anderson Cancer Center ...

PET scan works by detecting radiation emitted by a radiotracer. Radiotracers are made of radioactive material tagged to a naturally occurring chemical, such as glucose. FDG is the most commonly ...

Dr. Niotis says the most common brain scans performed are Amyloid PET scans and FDG-PET scans. "Amyloid PET scans tell us if someone has accumulated the toxic protein Amyloid-Beta that is ...

Many types of cancer cells use a lot of glucose, so they show up as hot spots on the scan. But F-FDG isn’t cancer-specific. So, PET scans may reveal hot spots that aren’t necessarily related ...

A new study from Brigham and Women's Hospital suggests that positron emission tomography (PET) brain scans could reveal hidden inflammation in patients with multiple sclerosis (MS) who are being ...

They need energy to grow. So, active cancer cells take up the FDG which then shows up brighter on the scan. Your radiographer takes you into the scanning room. The PET machine is large and shaped like ...

PET is a scan that uses a tracer to show tumor activity. Research published in 2017 indicates that lymphoma cells are particularly responsive to a tracer called fluorodeoxyglucose (FDG).